Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on...
Groups Seek Generic Competition for Abbott’s Patented Lifesaving Treatments WASHINGTON, D.C. – Today, public health groups in a dozen countries launch a campaign to challenge Abbott Laboratories’...
View ArticleSouth Centre Relases Brief on the State of Implementation of the Doha...
The South Centre has released a new policy brief on the state of the implementation of the Doha Declaration on TRIPS and Public Health. It hails the Doha Declaration as a “landmark achievement for...
View ArticleColombian Court: Abbott Labs’ AIDS Drug Pricing Abuse Violated Health Rights
Both sides appeal in ongoing civil society lawsuit for compulsory license A Colombian administrative judge has ruled that Abbott Laboratories and the Ministry of Health threatened and violated...
View ArticleMalaysian Civil Society Groups Seek Compulsory License for Second Line...
Earlier this month, the Malaysian AIDS council, an umbrella group of 49 civil society groups, asked the Malaysian Minister of Health to begin a government sponsored program to provide second line...
View ArticleChina Revises Law to Facilitate Compulsory Licenses for Generic Medicines
China has revised its legal framework to promote compulsory licenses for patented medicines to meet public health needs. The government is considering issuing a compulsory license for tenofovir, a...
View ArticleThai Civil Society Groups Oppose Patent Application for HIV/AIDS Treatment
A coalition of Thai civil society groups has written a letter opposing Gilead’s patents for the fixed-dose combination of AVR tenofovir and emtricitaine (TDF+FTC, sold under the brand name Truvada), an...
View ArticleEnding the HIV/AIDS Epidemic Act of 2012 Introduced, Aims to Protect Flexible...
Last night, Congresswoman Barbara Lee introduced the Ending the HIV/AIDS Epidemic Act of 2012 (HR 6138). One section of the bill aims at protecting the use of flexible intellectual property policies...
View ArticleTreating People Right Means Taking the IP Yoke Off Our Back: A 10 Point Plan...
[Reposted from treatpeopleright.org] “Treating people right” means many things, but one of the things it means is that people living with and at risk of HIV/AIDS must have immediate and affordable...
View ArticleIntellectual Property Policy Incoherence at the African Union Threatens...
Proposed Pan-African IP Organization a Terrible Idea In a stunning development, following an obscure vote of Heads of State at the Africa Union in 2007 (Assembly Council/AU/Dec. 138(VIII)), the AU...
View ArticleAdvocates Ask De Gucht to Leave Data Exclusivity Out of Trade Agreement with...
Health advocates have asked the EU not to include data exclusivity requirements in the “Deeply Comprehensive Free Trade Agreement” that is being negotiated between the EU and Moldova. Article 9 of the...
View ArticleMedicines Patent Pool, ViiV Healthcare Collaborate to Treat Paediatric HIV
[MPP press release, (CC-BY-NC-ND)] The Medicines Patent Pool (MPP) today announces the launch of a new collaboration with ViiV Healthcare – a joint venture of GlaxoSmithKline, Pfizer, and Shionogi –...
View ArticleAnalysis: India’s Supreme Court Upholds Strict Patent Standards and Patients’...
In a stunning victory for poor patients throughout the developing world, the Indian Supreme Court today ruled against a Novartis challenge of a denial of a patent on its cancer medicine Glivec.[1] The...
View ArticleCambodian People’s Statement on the EU-India Free Trade Agreement on Generic...
We have been informed about the repeated attempt of the EU to include Intellectual Property Rights provisions that are very likely to undermine the stable supply of affordable life-saving medicines to...
View ArticleAttack on affordable medicines continues in EU-India trade negotiations
Health groups rally in Delhi as protests spread across the developing world. [Posted on the Don't Trade Our Lives Away blog, 10 April, 2013, New Delhi] Thousands of people living with HIV, cancer...
View ArticleSouth Africa’s Department of Trade and Industry Reneges on IP Policy Commitments
[Posted on FixthePatentLaws.org (Link)] On 24 April 2013, Minister of Trade and Industry Rob Davies stated that South Africa’s new intellectual property (IP) policy would not be released for public...
View ArticleUS Government Special 301 “Watchlist” and Developing Country Use of...
Special 301 is an annual report by the Office of the US Trade Representative (USTR) which places countries on a “watch list” if USTR would like to see greater changes in their intellectual property...
View ArticleIncoming WTO Director General Urged to Make Access to Medicines a Priority
Least-developed countries fighting for TRIPS exemption extension [MSF Press Release] On the appointment of Roberto Azevedo as Director General of the World Trade Organization, international medical...
View ArticleTrans Pacific Partnership Negotiations and the Controversial Issue of...
Trade negotiators are meeting in Lima, Peru this week for the seventeenth round of talks on the proposed Trans Pacific Partnership (TPP). The negotiations are reaching the final stages as an October...
View ArticleSouth to Introduce Resolution on Access to Medicines
(Reposted with permission from the TWN Info Service) Developing countries are set to introduce a resolution on access to medicines at the current session of the United Nations Human Rights Council. The...
View ArticleRoche relinquishes Trastuzumab patent in India: Campaign urges fast track...
KALYANI MENON-SEN Campaign for Affordable Trastuzumab +91-9910306382 Swiss pharma major Roche has just announced that it is relinquishing the patent for its breast-cancer drug Trastuzumab (Herceptin)...
View Article